Page 1514 - Williams Hematology ( PDFDrive )
P. 1514
1488 Part X: Malignant Myeloid Diseases Chapter 89: Chronic Myelogenous Leukemia and Related Disorders 1489
947. Lahortiga I, Akin C, Cools J, et al: Activity of imatinib in systemic mastocytosis with 980. Tuohey EL: A case of splenomegaly with polymorphonuclear neutrophil hyperleuko-
chronic basophilic leukemia and a PRKG2-PDGFRB fusion. Haematologica 93:49, cytosis. Am J Med Sci 160:18, 1920.
2008. 981. Froberg MK, Brunning RD, Dorion P, et al: Demonstration of clonality in neutrophils
948. Castro-Malaspina H, Schaison G, Brier J, et al: Philadelphia chromosome positive using FISH in a case of chronic neutrophilic leukemia. Leukemia 12:623, 1998.
chronic myelocytic leukemia in children: Survival and prognostic factors. Cancer 982. Böhm J, Schaefer HE: Chronic neutrophilic leukemia:14 new cases of an uncommon
51:721, 1983. myeloproliferative disorder. J Clin Pathol 55:862, 2002.
949. Arico M, Biondi A, Pui C-H: Juvenile myelomonocytic leukemia. Blood 90:479, 1997. 983. Standen GR, Steers FJ, Jones L: Clonality in chronic neutrophilic leukemia associated
950. Neimeyer CM, Arico M, Basso A, et al: Chronic myelomonocytic leukemia in child- with myeloma: Analysis using the X-linked probe M27 beta. J Clin Pathol 46:297, 1993.
hood. Blood 89:3535, 1997. 984. Bohm J, Kock S, Schaefer HE, Fisch P: Evidence of clonality in chronic neutrophilic
951. Emanuel PD: Juvenile myelomonocytic leukemia and chronic myelomonocytic leuke- leukaemia. J Clin Pathol 56:292, 2003.
mia. Leukemia 22:1335, 2008. 985. Yanagisawa K, Ohminami H, Sato M, et al: Neoplastic involvement of granulocytic
952. Niemeyer CM, Kratz C: Juvenile myelomonocytic leukemia. Curr Oncol Rep 5:510, lineage, not granulocytic-monocytic, monocytic, or erythrocytic lineage, in a patient
2003. with chronic neutrophilic leukemia. Am J Hematol 57:221, 1998.
953. Busque L, Gilliland DG, Prchal JT, et al: Clonality in juvenile chronic myelogenous 986. Hasegawa T, Suzuki K, Sakamoto C, et al: Expression of the inhibitor of apoptosis
leukemia. Blood 85:21, 1995. (IAP) family members in human neutrophils: Up-regulation of cIAP2 in chronic neu-
954. Cooper LJN, Shannon KM, Loken MR, et al: Evidence that juvenile chronic myelo- trophilic leukemia. Blood 101:1164, 2003.
monocytic leukemia can arise from a pluripotential stem cell. Blood 96:2310, 2000. 987. Hasle H, Olesen G, Kerndrup G, et al: Chronic neutrophilic leukaemia in adolescence
955. Emanuel PD: RAS pathway mutations in juvenile myelomonocytic leukemia. Acta and young adulthood. Br J Haematol 94:628, 1996.
Haematol 119:207, 2008. 988. Elliott MA, Dewald GW, Tefferi A, Hanson CA: Chronic neutrophilic leukemia
956. Guilbert-Douet N, Morel F, Le Bris M-J, et al: Somatic PTPN11 mutation with a (CNL): A clinical and pathological entity. Leukemia 15:35, 2001.
heterogeneous clonal origin in children with juvenile myelomonocytic leukemia. 989. Reilly JT: Chronic neutrophilic leukaemia: A distinct clinical entity? Br J Haematol
Leukemia 18:1142, 2004. 116:10, 2002.
957. Gandre-Babbe S, Paluru P, Aribeana C, Chou ST, et al: Patient-derived induced 990. Elliott MA: Chronic neutrophilic leukemia. Curr Hematol Rep 3:210, 2004.
pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelo- 991. Gotlib J, Maxson JE, George TI, Tyner JW. The new genetics of chronic neutrophilic
monocytic leukemia. Blood 121:4925, 2013. leukemia and atypical CML: Implications for diagnosis and treatment. Blood 122:1707,
958. Miyauchi J, Asada M, Sasaki M, et al: Mutations of the N-ras gene in juvenile chronic 2013.
myelogenous leukemia. Blood 83:2248, 1994. 992. Ortiz-Cruz K, Amog-Jones G, Salvatore JR: Chronic neutrophilic leukemia with JAK2
959. Bader JL, Miller RW: Neurofibromatosis and childhood leukemia. J Pediatr 92:925, gene mutation. Clin Commun Oncol 9:127, 2012.
1978. 993. Fleischman AG, Maxson JE, Luty SB et al: The CSF3R T618I mutation causes a lethal
960. Brodeur GM: The NF1 gene in myelopoiesis and childhood myelodysplastic syn- neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition. Blood
drome. N Engl J Med 330:637, 1994. 122:3628, 2013.
961. Shannon KM: Loss of normal NF1 allele from the bone marrow of children with type 994. Piliotis E, Kutas G, Lipton JH: Allogeneic bone marrow transplantation in the man-
1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330:597, 1994. agement of chronic neutrophilic leukemia. Leuk Lymphoma 43:2051, 2002.
962. Bollag G: Loss of NF1 results in activation of RAS signaling pathway and leads to 995. Ito T, Kojima H, Otani K, et al: Chronic neutrophilic leukemia associated with mono-
aberrant growth in haematopoietic cells. Nat Genet 12:137, 1996. clonal gammopathy of undetermined significance. Acta Haematol 95:140, 1996.
963. Tartaglia M, Niemeyer CM, Fragale A, et al: Somatic mutations in PTPN11 in juvenile 996. Vorobiof DA, Benjamin J, Kaplan H, Dvilansky A: Chronic granulocytic leukemia,
myelomonocytic leukemia, myelodysplastic syndrome and acute myeloid leukemia. neutrophilic type with paraproteinemia (IgA type K). Acta Haematol 60:316, 1978.
Nat Genet 34:148, 2003. 997. Carcassonne Y, Gastaut JA, Sebahoun G, Gratecos N: Découverte simultanée chez
964. Owen G, Lewis IJ, Morgan M, et al: Prognostic factors in juvenile chronic granulocytic un même malade d’un myélome, d’une leucémie granuleuse (à polynucléaires neu-
leukaemia. Br J Cancer Suppl 18:S68, 1992. trophils) et d’une maladie de Paget. Nouv Rev Fr Hematol 18:240, 1977.
965. Estrov Z, Grunberger T, Chan HS, Freedman MH: Juvenile chronic myelogenous leu- 998. Franchi F, Seminara P, Gruinchi G: Chronic neutrophilic leukemia and myeloma.
kemia. Characterization of the disease using cell cultures. Blood 67:1382, 1986. Report on long survival. Tumori 70:105, 1984.
966. Estrov Z, Dube ID, Chan HS, Freedman MH: Residual juvenile chronic myelogenous 999. Lewis MJ, Oelbaum MH, Coleman M, Allen S: An association between chronic
leukemia cells detected in peripheral blood during clinical remission. Blood 70:1466, neutrophilic leukaemia and multiple myeloma with a study of cobalamin-binding
1987. proteins. Br J Haematol 63:173, 1986.
967. Emanuel PD, Bates LJ, Zhu SW, et al: The role of monocyte-derived hemopoietic 1000. Rovira M, Cervantes F, Namdedeu B, Rozman C: Chronic neutrophilic leukaemia
growth factors in the regulation of myeloproliferation in juvenile chronic myeloge- preceding for seven years the development of multiple myeloma. Acta Haematol 3:94,
nous leukemia. Exp Hematol 19:1017, 1991. 1990.
968. Morerio C, Acquila M, Rosanda C, et al: HCMOGT-1 is a novel fusion partner to 1001. Standen GR, Jasani B, Wagstaff M, Wardrop CAJ: Chronic neutrophilic leukemia and
PDGFRB in juvenile myelomonocytic leukemia with t(5;17)(q33;p11.2). Cancer Res multiple myeloma. Cancer 66:162, 1990.
64:2649, 2004. 1002. Nagai M, Oda S, Iwamoto M, et al: Granulocyte-colony stimulating factor
969. Inoue S, Ravindranath Y, Thompson RI, et al: Cytogenetics of juvenile type chronic concentrates in a patient with plasma cell dyscrasia and clinical features of chronic
granulocytic leukemia. Cancer 39:2017, 1977. neutrophilic leukaemia. J Clin Pathol 49:858, 1996.
970. Brodeur GM, Dow LW, Williams DL: Cytogenetic features of juvenile chronic myelog- 1003. Dinçol G, Nalçaci M, Dogan O, et al: Coexistence of chronic neutrophilic leukemia
enous leukemia. Blood 53:812, 1979. with multiple myeloma. Leuk Lymphoma 43:649, 2002.
971. Chan HS, Estrov Z, Weitzman SS, Freedman MH: The value of intensive combination 1004. Masini L, Salvarani C, Macchioni P, et al: Chronic neutrophilic leukemia (CNL) with
chemotherapy for juvenile chronic myelogenous leukemia. J Clin Oncol 5:1960, 1987. karyotype abnormalities associated with plasma cell dyscrasia. Haematologica 77:277,
972. Kang HJ, Shin HY, Choi HS, Ahn HS: Novel regimen for the treatment of juvenile 1992.
myelomonocytic leukemia (JMML). Leuk Res 28:167, 2004. 1005. Pascucci M, Dorion P, Makary A, Froberg MK: Chronic neutrophilic leukemia evolv-
973. Pui CH, Arico M: Isotretinoin for juvenile chronic myelogenous leukemia. N Engl J ing from the myelodysplastic syndrome. Acta Haematol 98:163, 1997.
Med 332:1520, 1995. 1006. Takamatsu Y, Kondo S, Inoue M, Tamura K: Chronic neutrophilic leukemia with dys-
974. Bernard F, Thomas C, Emile JF, et al: Transient hematologic and clinical effects of plastic features mimicking myelodysplastic syndrome. Int J Hematol 63:65, 1996.
E21R in a child with end-stage juvenile myelomonocytic leukemia. Blood 99:2615, 1007. Higuchi T, Oba R, Endo M, et al: Transition of polycythemia vera to chronic neu-
2002. trophilic leukemia. Leuk Lymphoma 33:203, 1999.
975. Locatelli F, Niemeyer C, Angelucci E, et al: Allogeneic bone marrow transplantation 1008. Billio A, Venturi R, Morello E, et al: Chronic neutrophilic leukemia evolving from
for chronic myelomonocytic leukemia in childhood. J Clin Oncol 15:556, 1997. polycythemia vera with multiple chromosome rearrangements: A case report.
976. Manabe A, Okamura J, Yumura-Yagi K, et al: Allogeneic hematopoietic stem cell trans- Haematologica 86:1225, 2001.
plantation for 27 children with juvenile myelomonocytic leukemia diagnosed based on 1009. Foa P, Iurlo A, Saglio G, et al: Chronic neutrophilic leukemia associated with
the criteria of the International JMML Working Group. Leukemia 16:645, 2002. polycythemia vera. Br J Haematol 78:286, 1991.
977. Locatelli F, Crotta A, Ruggeri A, et al: Analysis of risk factors influencing outcomes 1010. Higuchi T, Oba R, Endo M, et al: Transition of polycythemia vera to chronic neu-
after cord blood transplantation in children with juvenile myelomonocytic leukemia: trophilic leukemia. Leuk Lymphoma 33:203, 1999.
A EUROCORD, EBMT, EWOG-MDS, CIBMTR study. Blood 122:2135, 2013. 1011. Iurlo A, Foa P, Mailo AT, et al: Polycythemia vera terminating in chronic neutrophilic
978. Worth A, Rao K, Webb D, et al: Successful treatment of juvenile myelomonocytic leukemia. Am J Hematol 35:139, 1990.
leukemia relapsing after stem cell transplantation using donor lymphocyte infusion. 1012. Soda H, Kuriyama K, Tomonaga M, et al: Lymphoid crisis with T-cell phenotypes
Blood 101:1713, 2003. in a patient with Philadelphia chromosome negative chronic myeloid leukemia. Br J
979. Scrideli CA, Baruffi MR, Rogatto SR, et al: B lineage acute lymphoblastic leukemia Haematol 59:671, 1985.
transformation in a child with juvenile myelomonocytic leukemia, type 1 neurofibro- 1013. Kessler JF, Grogan TM, Greenberg BR: Philadelphia-chromosome-negative chronic
matosis and monosomy of chromosome 7. Possible implications in the leukemogene- myelogenous leukemia with lymphoid stem cell blastic transformation. Am J Hematol
sis. Leuk Res 27:371, 2003. 18:201, 1985.
Kaushansky_chapter 89_p1437-1490.indd 1489 9/18/15 3:42 PM

